Marvell Technology, Inc. filings document the company’s operating results, capital-markets activity and governance matters as a Nasdaq-listed semiconductor issuer. Recent 8-K disclosures cover quarterly and fiscal-year results, dividend declarations, senior note financing under an automatic shelf registration statement, prospectus supplement exhibits and related legal opinions.
The filings also describe MRVL capital-structure changes, including Series A Convertible Preferred Stock issued to NVIDIA Corporation, certificate of designation terms, debt indenture provisions and unregistered common-stock issuances tied to the completed Celestial AI acquisition. These records address securities registration, financing terms, conversion mechanics, exhibits and other material events affecting the company’s equity and debt structure.
Marvell Technology SVP and Chief Accounting Officer Justin Scarpulla had restricted stock units vest on July 15, 2026, delivering 510 shares of common stock. 253 shares were surrendered to cover tax withholding, leaving 413 shares held directly and 5,610 RSUs scheduled to vest through April 15, 2029.
Matthew J. Murphy, Chairman of the Board and CEO of Marvell Technology, Inc., reported multiple equity compensation-related transactions in Common Stock and Restricted Stock Units on July 15, 2026. He acquired 21,497 shares through the vesting and conversion of Restricted Stock Units.
To cover related obligations, 11,320 shares were surrendered for tax withholding at $206.26 per share, and 7,500 shares were sold in the open market at a weighted average price of $209.52 per share under a pre-arranged 10b5-1 Plan. After these transactions, he directly holds 780,509 Common shares and 20,906 Restricted Stock Units, with remaining units scheduled to vest on various dates from October 15, 2026 through April 15, 2029.
Marvell Technology, Inc. (MRVL) has a Form 144 notice from reporting person Sandeep Bharathi to sell up to 9,013 shares of common stock through Morgan Stanley Smith Barney on NASDAQ around July 16, 2026, valued at about $1,795,778.06. A prior sale on June 16, 2026 disposed of 2,231 shares for $667,359.03. Common shares outstanding are 874,800,000.
Marvell Technology, Inc. filed a current report to attach a legal opinion supporting a new prospectus supplement under its automatic shelf registration statement on Form S-3. The opinion from Wilson Sonsini Goodrich & Rosati addresses the legality of issuing and selling the securities described in that prospectus supplement.
Marvell Technology, Inc. registers 146,504 shares of common stock for resale by selling securityholders. These shares were issued in connection with Marvell’s acquisition of XConn Technologies Holdings, Ltd. and Marvell will not receive any proceeds from sales under this prospectus supplement.
The selling securityholders may sell any or all of the shares through public or private transactions at market, negotiated or other prices, and timing is within each selling securityholder’s sole discretion, subject to the stated restrictions and the plan of distribution in the supplement.
Marvell Technology, Inc. President and COO Chris Koopmans reported an open‑market sale of 10,000 shares of common stock. The shares were sold at a weighted average price of $281.92 per share and are held indirectly through the Christopher R. Koopmans and Heather J. Koopmans Family Trust.
The sale was executed pursuant to a pre‑arranged Rule 10b5‑1 trading plan adopted on January 5, 2026. Following this transaction, total reported holdings are 227,754 shares, which include 362 shares purchased on June 5, 2026 under Marvell’s Employee Stock Purchase Plan.
The filing is a Form 144 notice for proposed resale of 10,000 common shares (performance shares) dated 05/15/2026. The excerpt also lists three reported sales by KOOPMANS FAMILY TRUST: 10,000 shares on 06/01/2026 ($2,058,657.00), 10,000 shares on 05/01/2026 ($1,627,644.00), and 10,000 shares on 04/06/2026 ($1,102,427.00).
House Rebecca W reported acquisition or exercise transactions in this Form 4 filing.
Marvell Technology director Rebecca W. House received a grant of 1,034 restricted stock units (RSUs). Each RSU represents the right to receive one share of Marvell common stock when it vests. Following this award, her reported RSU holdings from this grant total 1,034 units.
The RSUs vest in full on the earlier of Marvell’s next annual meeting of stockholders or the one-year anniversary of the grant date. This is a compensation-related equity award and not an open-market share purchase or sale.
Knight Marachel reported acquisition or exercise transactions in this Form 4 filing.
Marvell Technology, Inc. director Marachel Knight reported compensation-related equity activity. On June 25, 2026, Knight received a grant of 1,034 Restricted Stock Units, each representing a contingent right to one share of common stock upon vesting. These RSUs vest in full on the earlier of Marvell’s next annual meeting of stockholders or the one-year anniversary of the grant date.
The filing also reflects 26,904 shares of common stock held indirectly through the Marachel L. Knight Revocable Living Trust, which Knight serves as sole trustee and beneficiary. This includes 3,940 shares transferred from direct to indirect ownership, described as not involving a change in beneficial ownership.
Marvell Technology, Inc. director Rajiv Ramaswami reported routine equity compensation activity. On June 25, 2026, 3,082 restricted stock units vested in full and were exercised into 3,082 shares of common stock, leaving him with 3,082 common shares directly owned.
On the same date, he also received a new grant of 1,034 restricted stock units, each representing one future share of common stock upon vesting. These 1,034 units vest in full on the earlier of Marvell’s next annual meeting of stockholders or the one-year anniversary of the grant date. No shares were sold in these transactions.